NASDAQ:BHST BioHarvest Sciences (BHST) Stock Price, News & Analysis $5.74 -0.41 (-6.67%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock About BioHarvest Sciences Stock (NASDAQ:BHST) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get BioHarvest Sciences alerts:Sign Up Key Stats Today's Range$5.60▼$6.4550-Day Range$4.95▼$6.7552-Week Range$5.60▼$7.38Volume54,064 shsAverage Volume8,677 shsMarket Capitalization$94.28 millionP/E RatioN/ADividend YieldN/APrice Target$13.00Consensus RatingBuy Company OverviewBioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.Read More… Remove Ads Receive BHST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioHarvest Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address BHST Stock News HeadlinesBioHarvest shares rise after Q4 results show strong demand for VINIA productsApril 1 at 1:06 PM | proactiveinvestors.comBioHarvest Sciences Inc. (BHST) Q4 2024 Earnings Conference Call TranscriptMarch 31 at 9:01 PM | seekingalpha.comYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.April 3, 2025 | Premier Gold Co (Ad)BioHarvest Sciences Inc.: BioHarvest In Vitro Testing Shows Proprietary Olive Cell Compound Reduces Fat Accumulation in Liver CellsMarch 4, 2025 | finanznachrichten.deBioHarvest Sciences Inc.'s (NASDAQ:BHST) Shift From Loss To ProfitFebruary 20, 2025 | finance.yahoo.comBioHarvest Sciences to Delist from CSE, Focuses on NasdaqFebruary 14, 2025 | tipranks.comBioHarvest Sciences Inc. (BHST)February 12, 2025 | finance.yahoo.comBioHarvest Sciences reports material changeJanuary 23, 2025 | msn.comSee More Headlines BHST Stock Analysis - Frequently Asked Questions How have BHST shares performed this year? BioHarvest Sciences' stock was trading at $6.18 at the beginning of 2025. Since then, BHST shares have decreased by 7.1% and is now trading at $5.74. View the best growth stocks for 2025 here. How were BioHarvest Sciences' earnings last quarter? BioHarvest Sciences Inc. (NASDAQ:BHST) issued its quarterly earnings data on Monday, March, 31st. The company reported ($0.17) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.05. The business had revenue of $7.17 million for the quarter, compared to analysts' expectations of $7.24 million. How do I buy shares of BioHarvest Sciences? Shares of BHST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings3/31/2025Today4/03/2025Next Earnings (Estimated)5/29/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:BHST Previous SymbolNASDAQ:BHST CIK1723464 Webbioharvest.com Phone646-863-2177FaxN/AEmployeesN/AYear FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$14.00 Low Stock Price Target$12.00 Potential Upside/Downside+126.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)($1.25) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-12,560,000.00 Net Margins-76.65% Pretax Margin-76.65% Return on EquityN/A Return on Assets-85.16% Debt Debt-to-Equity RatioN/A Current Ratio0.80 Quick Ratio0.48 Sales & Book Value Annual Sales$22.43 million Price / Sales4.20 Cash FlowN/A Price / Cash FlowN/A Book Value($1.08) per share Price / Book-5.31Miscellaneous Outstanding Shares16,425,000Free FloatN/AMarket Cap$94.28 million OptionableN/A Beta2.27 5G Stocks: The Path Forward is ProfitableEnter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report This page (NASDAQ:BHST) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioHarvest Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioHarvest Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.